English: 100MG Capsule 02244725 GLEEVEC NVR 100MG Tablet 02253275 GLEEVEC NVR 400MG Tablet 02253283 GLEEVEC NOV INTERFERON ALFA-2A 9,000,000IU/ML Injection 02217058 ROFERON-A HLR INTERFERON ALFA-2B 6,000,000IU/ML Injection 02238674 INTRON A SCH 10,000,000IU/ML Injection 02238675 INTRON A SCH 10,000,000IU/VIAL Injection 02223406 INTRON A SCH 15,000,000IU/ML Injection 02240693 INTRON A SCH 18,000,000IU/VIAL Injection 02231651 INTRON A SCH 25,000,000IU/ML Injection 02240694 INTRON A SCH 50,000,000IU/ML Injection 02240695 INTRON A SCH LETROZOLE 2.5MG Tablet 02231384 FEMARA NVR LEUPROLIDE ACETATE 3.75MG/VIAL Injection 00884502 LUPRON DEPOT ABB 7.5MG/VIAL Injection 00836273 LUPRON DEPOT ABB 11.25MG/VIAL Injection 02239834 LUPRON DEPOT ABB 22.5MG/VIAL Injection 02248240 ELIGARD SAC 02230248 LUPRON DEPOT ABB 30MG/VIAL Injection 02248999 ELIGARD SAC 02239833 LUPRON DEPOT ABB 45MG/VIAL Injection 02268892 ELIGARD SAC LOMUSTINE 10MG Capsule 00360430 CEENU BMS 40MG Capsule 00360422 CEENU BMS 100MG Capsule 00360414 CEENU BMS MEGESTROL ACETATE 40MG/ML Suspension 02168979 MEGACE BMS 40MG Tablet 02195917 APO-MEGESTROL APX 02223104 MEGESTROL PDL 02185415 NU-MEGESTROL NXP 160MG Tablet 02195925 APO-MEGESTROL APX 00731323 MEGACE BMS 02223112 MEGESTROL PDL 02185423 NU-MEGESTROL NXP MELPHALAN 2MG Tablet 00004715 ALKERAN GSK MERCAPTOPURINE 50MG Tablet 00004723 PURINETHOL NOP METHOTREXATE SODIUM 10MG/ML Injection 02182947 METHOTREXATE MAY 25MG/ML Injection 02182777 METHOTREXATE MAY 02182955 METHOTREXATE MAY 02099705 NOVO-METHOTREXATE NOP 2.5MG Tablet 02182963 APO-METHOTREXATE APX 02170698 METHOTREXATE WAY 02244798 RATIO-METHOTREXATE RPH 10MG Tablet 02182750 METHOTREXATE MAY MITOTANE 500MG Tablet 00463221 LYSODREN BMS NILUTAMIDE 50MG Tablet 02221861 ANANDRON SAC PROCARBAZINE HCL 50MG Capsule 00012750 NATULAN SIG RITUXIMAB Limited use benefit (prior approval required).  Prescribed by a rheumatologist for treatment of adult patients with severely active rheumatoid arthritis who have failed to respond to a trial of an anti-TNF agent.
French: 100MG Capsule 02244725 GLEEVEC NVR 100MG Comprimé 02253275 GLEEVEC NVR 400MG Comprimé 02253283 GLEEVEC NOV INTERFÉRON ALPHA-2A 9,000,000IU/ML Injection 02217058 ROFERON-A HLR INTERFÉRON ALPHA-2B 6,000,000IU/ML Injection 02238674 INTRON A SCH 10,000,000IU/ML Injection 02238675 INTRON A SCH 10,000,000IU/VIAL Injection 02223406 INTRON A SCH 15,000,000IU/ML Injection 02240693 INTRON A SCH 18,000,000IU/VIAL Injection 02231651 INTRON A SCH 25,000,000IU/ML Injection 02240694 INTRON A SCH 50,000,000IU/ML Injection 02240695 INTRON A SCH LEUPROLIDE (ACÉTATE DE) 3.75MG/VIAL Injection 00884502 LUPRON DEPOT ABB 7.5MG/VIAL Injection 00836273 LUPRON DEPOT ABB 11.25MG/VIAL Injection 02239834 LUPRON DEPOT ABB 22.5MG/VIAL Injection 02248240 ELIGARD SAC 02230248 LUPRON DEPOT ABB 30MG/VIAL Injection 02248999 ELIGARD SAC 02239833 LUPRON DEPOT ABB 45MG/VIAL Injection 02268892 ELIGARD SAC LOMUSTINE 10MG Capsule 00360430 CEENU BMS 40MG Capsule 00360422 CEENU BMS 100MG Capsule 00360414 CEENU BMS LÉTROZOLE 2.5MG Comprimé 02231384 FEMARA NVR MELPHALAN 2MG Comprimé 00004715 ALKERAN GSK MERCAPTOPURINE 50MG Comprimé 00004723 PURINETHOL NOP MITOTANE 500MG Comprimé 00463221 LYSODREN BMS MÉGESTROL (ACÉTATE DE) 40MG Comprimé 02195917 APO-MEGESTROL APX 02223104 MEGESTROL PDL 02185415 NU-MEGESTROL NXP 160MG Comprimé 02195925 APO-MEGESTROL APX 00731323 MEGACE BMS 02223112 MEGESTROL PDL 02185423 NU-MEGESTROL NXP 40MG/ML Suspension 02168979 MEGACE BMS MÉTHOTREXATE SODIQUE 2.5MG Comprimé 02182963 APO-METHOTREXATE APX 02170698 METHOTREXATE WAY 02244798 RATIO-METHOTREXATE RPH 10MG Comprimé 02182750 METHOTREXATE MAY 10MG/ML Injection 02182947 METHOTREXATE MAY 25MG/ML Injection 02182777 METHOTREXATE MAY 02182955 METHOTREXATE MAY 02099705 NOVO-METHOTREXATE NOP NILUTAMIDE 50MG Comprimé 02221861 ANANDRON SAC PROCARBAZINE (CHLORHYDRATE DE) 50MG Capsule 00012750 NATULAN SIG RITUXIMAB Médicament à usage restreint (autorisation préalable nécessaire).  Doit être prescrit par un rhumatologue pour le traitement de la polyarthrite rhumatoïde évolutive grave chez les adultes ayant montré une réponse inadéquate ou ont eu des effets secondaires à un traitement avec un inhibiteur du facteur de nécrose tumorale (anti-TNF).